These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33216017)

  • 21. Modified contrast-enhanced ultrasonography with the new high-resolution examination technique of high frame rate contrast-enhanced ultrasound (HiFR-CEUS) for characterization of liver lesions: First results.
    Jung EM; Moran VO; Engel M; Krüger-Genge A; Stroszczynski C; Jung F
    Clin Hemorheol Microcirc; 2023; 83(1):31-46. PubMed ID: 35466932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Value of CEUS Prompting Liver Biopsy: Histopathological Correlation of Hepatic Lesions with Ambiguous Imaging Characteristics.
    Geyer T; Clevert DA; Schwarz S; Reidler P; Gassenmaier S; Knösel T; Rübenthaler J; Schwarze V; Armbruster M
    Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33375514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced ultrasound (CEUS) and gallbladder diseases - A retrospective mono-center analysis of imaging findings with histopathological correlation.
    Negrão de Figueiredo G; Mueller-Peltzer K; Zengel P; Armbruster M; Rübenthaler J; Clevert DA
    Clin Hemorheol Microcirc; 2019; 71(2):151-158. PubMed ID: 30584127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.
    Yue WW; Wang S; Xu HX; Sun LP; Guo LH; Bo XW; Li XL; Zhao CK; Wang D; Liu BJ
    Clin Hemorheol Microcirc; 2016 Nov; 64(2):177-188. PubMed ID: 27258196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-Center Study: Evaluating the Diagnostic Performance and Safety of Contrast-Enhanced Ultrasound (CEUS) in Pregnant Women to Assess Hepatic Lesions.
    Schwarze V; Marschner C; Negrão de Figueiredo G; Rübenthaler J; Clevert DA
    Ultraschall Med; 2020 Feb; 41(1):29-35. PubMed ID: 31362328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
    Sawatzki M; Meyenberger C; Brand S; Semela D
    Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
    Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
    Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation.
    Wang Y; Jing X; Ding J
    Clin Imaging; 2016; 40(3):402-6. PubMed ID: 27133676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-Enhanced Ultrasound in the Short-Term Evaluation of Hepatocellular Carcinoma after Locoregional Treatment.
    Ainora ME; Iezzi R; Ponziani FR; Garcovich M; Di Stasio E; Riccardi L; Annicchiarico BE; Abbate V; De Gaetano AM; Siciliano M; Grieco A; Rapaccini GL; Gasbarrini A; Pompili M; Zocco MA
    Dig Dis; 2020; 38(6):522-533. PubMed ID: 32053816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
    Seitz K; Strobel D
    Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Bosniak III Complex Renal Cystic Lesions-A 10-Year Specialized European Single-Center Experience with Histopathological Validation.
    Schwarze V; Rübenthaler J; Čečatka S; Marschner C; Froelich MF; Sabel BO; Staehler M; Knösel T; Geyer T; Clevert DA
    Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33322683
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnostic performance of contrast-enhanced ultrasound (CEUS) for the evaluation of gallbladder diseases1.
    Negrão de Figueiredo G; Mueller-Peltzer K; Zengel P; Armbruster M; Rübenthaler J; Clevert DA
    Clin Hemorheol Microcirc; 2018; 69(1-2):83-91. PubMed ID: 29630541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI?
    Tan Z; Teoh WC; Wong KM; Wansaicheong GK; Sandrasegaran K
    Clin Imaging; 2020 Jun; 62():63-68. PubMed ID: 32070868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
    Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-Enhanced Ultrasound: a Simple and Effective Tool in Defining a Rapid Diagnostic Work-up for Small Nodules Detected in Cirrhotic Patients during Surveillance.
    Giorgio A; Montesarchio L; Gatti P; Amendola F; Matteucci P; Santoro B; Merola MG; Merola F; Coppola C; Giorgio V
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):205-11. PubMed ID: 27308652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
    Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
    Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST.
    Liu M; Lin MX; Lu MD; Xu ZF; Zheng KG; Wang W; Kuang M; Zhuang WQ; Xie XY
    Eur Radiol; 2015 Aug; 25(8):2502-11. PubMed ID: 25702094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEUS: An essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma.
    Jang HJ; Kim TK; Burns PN; Wilson SR
    Eur J Radiol; 2015 Sep; 84(9):1623-35. PubMed ID: 26092406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.